A Froedtert surgeon used FDA‑approved Cytalux to make a tiny lung tumor glow during surgery, allowing a lung‑sparing removal. The technology may widen options for high‑risk patients.

SUNY researchers say dim indoor light during close-up work may be driving the rise in nearsightedness and offer simple fixes for parents, schools and commuters.

The FDA cleared Optune Pax, a wearable tumor‑treating‑fields device, after a Phase 3 trial showed a small survival benefit and delayed pain progression for inoperable pancreatic cancer.

A Miami judge refused to wipe out a $243M jury award tied to a 2019 Key Largo crash, leaving Tesla to defend the landmark Autopilot liability ruling as an appeal looms.

A Zoom hearing in 2023 produced a suspected deepfake that ended the session and left a sanctions motion pending, pushing Miami courts to require AI disclosures.

A Christ Hospital team used a catheter, stent and electrocautery to reopen a blocked graft stump for a 70‑year‑old patient previously told there were no options.

A tiny retinal chip and smart glasses helped a Pittsburgh trial participant begin to see forms again. An international study published last year reported meaningful improvement for most wearers.

Apple has started sending payments from its $95M Siri settlement; deposits labeled “Lopez Voice Assistant” began arriving on Jan. 23, 2026. Recipients are reporting modest payouts per device.

St. Louis County Health Department offers tips for accurate home blood pressure monitoring, stressing the importance of avoiding certain activities before taking a measurement and maintaining proper posture and cuff placement for reliable results.

Phil Spencer is retiring after nearly 40 years at Microsoft. Asha Sharma will lead Microsoft Gaming while Matt Booty is promoted and Xbox president Sarah Bond departs.

Jonathan Haidt's book and public push have helped move age-based social media limits from debate into law and school policy. The science is contested and young people want a voice.

A Fort Collins neurologist pairs EEG headsets and AI to estimate "brain age," aiming to flag early dementia and seizure risk as new laws move to protect neural data.

Rev1 opened a 43,000‑square‑foot startup hub at The Peninsula in Franklinton, offering Founder Lounge, Scale‑Up Suites and programming aimed at software and AI founders. The move puts Rev1 closer to downtown customers and investors.